{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:18:42Z","timestamp":1787023122760,"version":"build-2736575974"},"reference-count":51,"publisher":"FapUNIFESP (SciELO)","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT BACKGROUND: H. pylori chronic atrophic gastritis is a premalignant lesion, and its staging, according to OLGA and OLGIM systems aims to identify patients at increased risk of developing gastric cancer and optimize their follow-up. GastroPanel\u00ae, serum biomarkers panel including pepsinogen I (PGI), pepsinogen II (PGII), Gastrin 17 (G17) and anti- H. pylori antibodies is a noninvasive test for adenocarcinoma risk assessment in chronic H. pylori gastritis patients. OBJECTIVE: Prospective study to evaluate the concordance between OLGA and OLGIM grading systems, as well as to evaluate GastroPanel\u00b4s performance in patients with premalignant lesions secondary to H. pylori chronic gastritis in Brazil. METHODS: Patients with H. pylori chronic gastritis with premalignant lesions confirmed by histology were recruited from the gastrointestinal clinic of a University Hospital. All participants underwent endoscopic examination with biopsies which were reported according to updated Sydney system and premalignant lesions grading systems (OLGA and OLGIM). Blood samples were collected for biomarkers serological analysis (GastroPanel\u00ae, Biohit, Helsinki, Finland). The cut off values used to define high risk patients were those recommended by the manufacturer: PGI \u226430 \u00b5m\/L and PGI\/PGII \u22643. RESULTS: 41 patients were recruited: 28 women, 13 men, mean age 67.3 (47-89, SD: 9.6) years. By OLGA system, were obtained: OLGA 0 (n=1), OLGA I (n=7), OLGA II (n=17), OLGA III (n=9), and OLGA IV (n=7). By OLGIM system, were obtained: OLGIM 0 (n=14), OLGIM I (n=5), OLGIM II (n=10), OLGIM III (n=10), and OLGIM IV (n=2). Regarding histological staging among patients staged as low risk (OLGA\/OLGIM 0, I and II) and high risk (OLGA\/OLGIM III and IV) for gastric cancer development, the concordance rate found between both classifications was 85.4%. Considering high risk patients, those patients thus included in at least one of the systems the final distribution of our sample considered 24 low-risk and 17 high-risk patients for the development of gastric cancer. To determine by GastroPanel\u00ae whether the patient would be at low or high risk of developing gastric cancer, PGI showed a sensitivity, specificity and accuracy of 0.47 (95%CI: 0.26-0.69), 0.67 (95%CI: 0.47-0.82), and 0.58 (95%CI: 0.43-0.72), respectively, while PGI\/PGII showed sensitivity, specificity and accuracy of 0.06 (95%CI: 0.01-0.27), 0.83 (95%CI: 0.64-0.93) and 0.51 (95%CI: 0.36-0.66), respectively. CONCLUSION: The histological classifications OLGA and OLGIM presented a substantial concordance rate among themselves. Simultaneous use of both histological classification systems increased the identification\u2019s rate of high-risk patients. Biomarker analysis was not effective to distinguish low to high risk patients in the studied population. Further studies are needed to validate its use in clinical practice in Brazil.<\/jats:p>","DOI":"10.1590\/s0004-2803.202100000-08","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T08:38:27Z","timestamp":1619167107000},"page":"39-47","source":"Crossref","is-referenced-by-count":9,"title":["HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE"],"prefix":"10.1590","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8028-6114","authenticated-orcid":false,"given":"Maria Clara Freitas","family":"COELHO","sequence":"first","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brasil; Faculdade de Ci\u00eancias M\u00e9dicas de Minas Gerais, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8187-6378","authenticated-orcid":false,"given":"Henrique Gomes","family":"RIBEIRO","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0506-9627","authenticated-orcid":false,"given":"Celio Geraldo de Oliveira","family":"GOMES","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0107-3506","authenticated-orcid":false,"given":"Frederico Passos","family":"MARINHO","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3278-8624","authenticated-orcid":false,"given":"Alfredo J A","family":"BARBOSA","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brasil; Universidade Federal de Minas Gerais, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8721-7696","authenticated-orcid":false,"given":"Luiz Gonzaga Vaz","family":"COELHO","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais, Brasil; Universidade Federal de Minas Gerais, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2021,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"1","author":"Marshall BJ","year":"1984","journal-title":"Lancet"},{"key":"ref2","first-page":"1","article-title":"Schistosomes, liver flukes and Helicobacter pylori. IARC. Working Group on the Evaluation of Carcinogenic Risks to Humans","volume":"61","year":"1994","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"Helicobacter pylori infection","volume":"347","author":"Suerbaum S","year":"2002","journal-title":"N Engl J Med"},{"key":"ref4","first-page":"6735","article-title":"Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention","volume":"52","author":"Correa P","year":"1992","journal-title":"Cancer Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2559.1995.tb00614.x","article-title":"Histopathology of gastroduodenal inflammation. The impact of Helicobacter pylori","volume":"26","author":"Wyatt JI","year":"1995","journal-title":"Histopathology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.3748\/wjg.v12.i35.5622","article-title":"Assessing risks for gastric cancer: new tools for pathologists","volume":"12","author":"Genta RM","year":"2006","journal-title":"World J Gastroenterol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/ijc.11680","article-title":"Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer","volume":"109","author":"Ohata H","year":"2004","journal-title":"Int J Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.291.2.187","article-title":"Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial","volume":"291","author":"Wong BC","year":"2004","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ijc.2910350206","article-title":"Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data","volume":"35","author":"Sipponen P","year":"1985","journal-title":"Int J Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.gastro.2008.01.071","article-title":"Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands","volume":"134","author":"de Vries AC","year":"2008","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"h3867","DOI":"10.1136\/bmj.h3867","article-title":"Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population","volume":"351","author":"Song H","year":"2015","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/gut.2006.106666","article-title":"Gastritis staging in clinical practice: the OLGA staging system","volume":"56","author":"Rugge M","year":"2007","journal-title":"Gut"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.gie.2009.12.029","article-title":"The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis","volume":"71","author":"Capelle LG","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1523-5378.2008.00599.x","article-title":"Assessment of atrophic gastritis using the OLGA system","volume":"13","author":"Satoh K","year":"2008","journal-title":"Helicobacter"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1365-2036.2012.05111.x","article-title":"First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA\/OLGIM stages and dysplasia","volume":"35","author":"Marcos-Pinto R","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/apt.12515","article-title":"Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems","volume":"38","author":"Cho SJ","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1590\/s0004-2803.201800000-20","article-title":"IV Brazilian Consensus Conference on Helicobacter pylori infection","volume":"55","author":"Coelho LG","year":"2018","journal-title":"Arq Gastroenterol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner P","year":"2017","journal-title":"Gut"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0016-5085(82)90118-4","article-title":"Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum","volume":"82","author":"Samloff IM","year":"1982","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.dld.2008.02.028","article-title":"Non-invasive tests in gastric diseases","volume":"40","author":"di Mario F","year":"2008","journal-title":"Dig Liv Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s00535-005-1677-x","article-title":"Serum pepsinogen concentrations as a measure of gastric acid secretion in Helicobacter pylori- negative and positive- Japanese subjects","volume":"40","author":"Iijima K","year":"2005","journal-title":"J Gastroenterol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cgh.2005.11.003","article-title":"Noninvasive versus histologic detection of gastric atrophy in a Hispanic population in North America","volume":"4","author":"Graham DY","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-230X-12-10","article-title":"Serological assessment of gastric mucosal atrophy in gastric cancer","volume":"12","author":"Bornschein J","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1258\/0969141041732184","article-title":"Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening","volume":"11","author":"Dinis-Ribeiro M","year":"2004","journal-title":"J Med Screen"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10120-006-0397-0","article-title":"Gastric cancer screening using the serum pepsinogen test method","volume":"9","author":"Miki K","year":"2006","journal-title":"Gastric Cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12876-017-0641-6","article-title":"The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research","volume":"17","author":"Tong Y","year":"2017","journal-title":"BMC Gastroenterology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1007\/s10620-009-0947-5","article-title":"The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology","volume":"54","author":"Leja M","year":"2009","journal-title":"Dig Dis Sci"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109783","article-title":"Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis","volume":"9","author":"Terasawa T","year":"2014","journal-title":"PloS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.21873\/anticanres.11083","article-title":"A panel of serum biomarkers (GastroPanel\u00ae) in non-invasive diagnosis of atrophic gastritis. Systematic review and meta-analysis","volume":"36","author":"Syrj\u00e4nen K","year":"2016","journal-title":"Anticancer Research"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/apt.14248","article-title":"Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis","volume":"46","author":"Zagari RM","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.4067\/S0034-98872007001200003","article-title":"Detecci\u00f3n de lesiones preneopl\u00e1sicas g\u00e1stricas mediante niveles s\u00e9ricos de pepsin\u00f3geno en poblaci\u00f3n chilena","volume":"135","author":"Fern\u00e1ndez F JI","year":"2007","journal-title":"Rev M\u00e9d Chile"},{"key":"ref32","first-page":"564","article-title":"Ethnic differences in serum pepsinogen levels among Japanese and non-Japanese Brazilian gastric cancer patients and controls","volume":"24","author":"Fahey MT","year":"2000","journal-title":"Cancer Detect Prev"},{"key":"ref33","first-page":"1161","article-title":"Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994","volume":"20","author":"Dixon MF","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.dld.2008.02.030","article-title":"OLGA staging of gastrites: a tutorial","volume":"40","author":"Rugge M","year":"2008","journal-title":"Dig Liver Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MEG.0000000000000065","article-title":"Prevalence of gastric precancerous conditions: a systematic review and meta-analysis","volume":"26","author":"Marques-Silva L","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10120-018-0812-3","article-title":"The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis","volume":"21","author":"Yue H","year":"2018","journal-title":"Gastric Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/s41395-018-0353-8","article-title":"OLGA Gastritis Staging for the prediction of gastric cancer risk: a long-term follow-up study of 7436 patients","volume":"113","author":"Rugge M","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/gutjnl-2017-314498","article-title":"Surveillance of premalignant gastric lesions: a multicentre prospective cohort study from low incidence regions","volume":"68","author":"den Hollander WJ","year":"2019","journal-title":"Gut"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0046-8177(96)90135-5","article-title":"Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis","volume":"27","author":"el-Zimaity HM","year":"1996","journal-title":"Hum Pathol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1365-2559.1999.00635.x","article-title":"Observer agreement on the grading of gastric atrophy","volume":"34","author":"Offerhaus GJ","year":"1999","journal-title":"Histopathology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0046-8177(99)90164-8","article-title":"Interobserver variability in application of the revised Sydney classification for gastritis","volume":"30","author":"Guarner J","year":"1999","journal-title":"Hum Pathol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00428-014-1544-3","article-title":"Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems","volume":"464","author":"Isajevs S","year":"2014","journal-title":"Virchows Arch"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/gutjnl-2016-311685","article-title":"Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial","volume":"67","author":"Mera RM","year":"2018","journal-title":"Gut"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000360615","article-title":"Clinical management of Helicobacter pylori: the Latin American perspective","volume":"32","author":"Coelho LG","year":"2014","journal-title":"Dig Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/gut.2004.055400","article-title":"Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study","volume":"54","author":"Watabe H","year":"2005","journal-title":"Gut"},{"key":"ref46","article-title":"The Diagnostic Value of Gastrin-17 Detection in Atrophic Gastritis: A Meta-Analysis","volume":"95","author":"Wang X","year":"2016","journal-title":"Medicine"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/MEG.0000000000000132","article-title":"Accuracy of GastroPanel for the diagnosis of atrophic gastritis","volume":"26","author":"McNicholl AG","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref48","first-page":"110","article-title":"Pepsin\u00f3geno y gastrina en el diagn\u00f3stico no invasivo de la atrofia g\u00e1strica: un estudio caso-control en poblaci\u00f3n peruana","volume":"31","author":"Colarossi A","year":"2011","journal-title":"Rev Gastroenterol Peru"},{"key":"ref49","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12597","article-title":"Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition","volume":"24","author":"Kato M","year":"2019","journal-title":"Helicobacter"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/a-0859-1883","article-title":"Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019","volume":"51","author":"Pimentel-Nunes P","year":"2019","journal-title":"Endoscopy"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/gutjnl-2018-318126","article-title":"British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma","volume":"68","author":"Banks M","year":"2019","journal-title":"Gut"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ag\/v58n1\/1678-4219-ag-58-01-39.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T02:30:03Z","timestamp":1724898603000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032021000100039&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["S0004-28032021000100039"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.202100000-08","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}